Objective: To use a cluster analysis of [
function/behavior. 6 The typical clinical presentation of AD can occur both in young-onset (<65 years) and late-onset (>65 years) patients, whereas the atypical clinical presentations tend to most commonly occur in young-onset patients. Magnetic resonance imaging (MRI) studies performed at the group level typically find that the different variants of AD are associated with different degrees of atrophy of the cortex and medial temporal lobe. Young-onset typical AD patients have been shown to have a greater degree of cortical atrophy compared to late-onset AD patients, which show patterns of atrophy restricted to the medial temporal lobe. [7] [8] [9] [10] Cortical atrophy is also typically observed in atypical AD patients, with these patients showing a relative sparing of medial temporal lobe structures. [11] [12] [13] Evidence from studies with neuroimaging and pathology suggest that these differing patterns relate to the distribution of underlying tau pathology in the brain, 5, [14] [15] [16] and therefore that tau topography is the key driver of both atrophy and clinical presentation in AD. Positron emission tomography (PET) ligands, such as [ 18 F]AV-1451, 17 are now available that allow the detection of tau in the brain during life, and hence allow the direct assessment of how tau topography relates to clinical presentation in AD. The [ 18 F]AV-1451 ligand has been shown to bind strongly to AD tau in autoradiographic studies [18] [19] [20] and shows striking uptake in AD patients. [21] [22] [23] [24] Recent group-level studies with [
18 F]AV-1451 have shown that the atypical variants of AD show striking cortical uptake of tau. 25, 26 Cortical uptake has also been observed in both young-onset and old-onset AD, although cortical uptake appears greater in youngonset AD. 27, 28 The aim of our study was to take an individual patient-level approach and utilize a straightforward cluster analysis of regional [ 18 F]AV-1451 uptake values blinded to clinical diagnosis, to determine how well tau topography matches with clinical presentation (typical versus atypical) and age in AD. Given previous neuroimaging and autopsy studies, we based the cluster analysis on tau uptake in the medial temporal lobe and neocortex with the hypothesis that the relative involvement of these two regions will explain much of the variability in clinical presentation in AD.
Patients and Methods

Subjects
We identified all patients with a clinical diagnosis of typical or atypical AD that had evidence of beta-amyloid deposition on Pittsburgh Compound B (PiB) PET and had undergone [ 18 F]AV-1451 tau-PET at Mayo Clinic (Rochester, MN). Sixtytwo patients were identified, of which 39 had early and significant memory impairment and were diagnosed with typical AD. 4 The remaining 23 patients were diagnosed with atypical AD, 6 of which 9 were diagnosed with posterior cortical atrophy, 29 7 were diagnosed with logopenic aphasia, 13 and 7 were diagnosed with behavioral/dysexecutive AD. 30 None of the subjects in the study met criteria for mild cognitive impairment. 31 These patients had been recruited as part of an NIH-funded grant studying atypical AD (PI Whitwell) Image Acquisition tau-PET imaging was performed using the [ 18 F]AV-1451 ligand and amyloid-PET imaging was performed using PiB-PET. All PET scans were acquired using a PET/computed tomography (CT) scanner (GE Healthcare, Milwaukee, WI) operating in three-dimensional mode. For tau-PET, an intravenous bolus injection of approximately 370MBq (range, 333-407) of [ 18 F]AV-1451 was administered, followed by a 20-minute PET acquisition performed from 80 to 100 minutes after injection. For PiB-PET, participants were injected with PiB of approximately 628MBq (range, 385-723) and a 20-minute PET acquisition was performed from 40 to 60 minutes after injection. Both 20-minute late-uptake PET scans consisted of four 5-minute dynamic frames following a low-dose CT image obtained for attenuation correction. Vendor supplied corrections for attenuation, scatter, and random corrections were applied. PET sinograms were iteratively reconstructed into a 256-mm field of view. The pixel size was 1.0mm and the slice thickness 3.3mm. The four individual frames of each dynamic series were averaged to create a 20-minute mean summed image that was used for analysis. All subjects had a 3-Tesla magnetization-prepared rapid gradient echo (MPRAGE) sequence performed on the same day as the tau-PET, as previously described. 32 PiB-PET scans were used as part of the inclusion criteria of the study to ensure all subjects had beta-amyloid deposition consistent with the presence of AD pathology. A global PiB standard uptake value ratio (SUVR) was generated as previously described 33 using the cerebellar crus gray matter as a reference region, and a cut point of 1.42 33 was used to define the presence of beta-amyloid deposition.
tau-PET Analysis
All image processing steps were performed using SPM12 (www. ]AV-1451 uptake in each ROI was divided by median uptake in cerebellar crus gray matter to create SUVRs. Regional gray matter volumes for the ERC and neocortical ROIs were summed from voxel-wise gray matter probabilities within the gray and white matter masks, within each atlas ROI. Total intracranial volumes were summed from the SPM12 gray, white, and cerebrospinal fluid (CSF) segmentations 37 and used to correct regional volumes for head size.
A voxel-level analysis was also performed to examine global patterns of uptake in each cluster compared to a cohort of 62 age-and sex-matched controls (median [interquartile range; IQR] age at PET 5 68 [59, 75] ; No. female 5 33 [53%]) that were selected from the Mayo Clinic Study of Aging. 38 The MCALT atlases in MPRAGE space were used to divide all voxels in the MPRAGE-space [
18 F]AV-1451 images by the median uptake in the cerebellar crus gray matter to create SUVR images. These SUVR images were normalized to the MCALT using SPM12 normalization parameters from the MPGRAGE and smoothed at 6mm full width at half maximum. Voxel-level comparisons were performed using two-sided t tests in SPM12, with results assessed at p < 0.001 after correction for multiple comparisons using the family-wise error correction. Age and sex were included in the analysis as covariates.
Statistical Analysis
We used the k-medians algorithm to cluster log-transformed entorhinal cortex and neocortical tau PET SUVR. When performing k-median clustering, we need to specify the number of clusters (k) beforehand. We used two methods to help us choose an appropriate number of clusters. First, we used the "elbow method," which utilizes the sum of within-cluster distances. We performed k-median clustering on the data set from two clusters to 10 clusters and for each number of clusters the sum of within-cluster distances was calculated. We then plotted the sum of within-cluster distances against the number of clusters (elbow plot). The sum of within-cluster distances will decrease with increasing number of clusters. The general idea is to try to minimize the sum of within-cluster distances, whereas choosing the smallest possible cluster size where adding one more cluster will offer little marginal improvements in the sum of within-cluster distances. Second, we assessed the stability, or reproducibility, of clusters by performing bootstrap resampling FIGURE 1: Analyses to determine appropriate number of clusters. Panel (A) shows a plot of sum of within-cluster distances by number of cluster performed using the elbow method. This plot shows decreasing sum of within-cluster distances with increasing cluster number. The aim is to try to minimize the sum of within-cluster distances, while choosing the smallest possible cluster size where adding one more cluster will offer little marginal improvements in the sum of within-cluster distances. Three clusters (ie, the elbow, highlighted in red) showed a large reduction in sum of within-cluster distances compared to just two clusters, with four clusters showing less additional reduction. Panel (B) shows box plots summarizing the adjusted Rand index (ARI) by number of cluster. The ARI reflects concordance in clustering when performing bootstrapping resampling. The ARI analysis showed that cluster stability was similar for both three and four clusters. Given the results from both methods, three clusters was determined to be the optimum number of clusters for this data set.
with 100 replicates. 39 For each replicate, two random samples were drawn with replacement and k-medians clustering was performed on each sample. The original subjects were then classified based on each of these replicate clusters, and the agreement, or concordance, was assessed by the adjusted Rand index (ARI). The ARI summarizes the fraction of all pairs of subjects for which the two replicate clusterings agree after accounting for chance agreement. 40, 41 Higher values of ARI indicate stronger agreement. We summarize the separation of the resulting clustering by a scatter plot of the two principal components and overlaying ellipses drawn to include all points in each cluster. Demographics, clinical, and cognitive variables were compared between the three clusters using Fisher's exact tests for categorical variables or nonparametric Kruskal-Wallis tests followed by Wilcoxon rank-sum tests for continuous variables. p < 0.05 was considered statistically significant. Analyses were performed with R statistical software (version 3.1.3; R Foundation for Statistical Computing, Vienna, Austria) and the "flexclust" package.
Results
Cluster Results
Based on the elbow method and the ARI statistics, we determined that three clusters were appropriate for this data set. The elbow method showed that three clusters appreciably reduced the sum of within-cluster distances compared to just two clusters, with four clusters showing less additional reduction (Fig 1A) . The ARI analysis showed that cluster stability was similar for both three and four clusters (Fig 1B) .
A scatter plot depicting the three clusters is shown in Figure 2A . One cluster (n 5 21) was characterized by relatively low tau uptake compared to the rest of the cohort in both the ERC and cortex (E Lo /C Lo ; red, Fig   2A) . The rest of the patients showed relatively high cortical tau uptake, with one cluster (n 5 21) characterized by relatively low ERC and high cortical uptake compared to the rest of the cohort (E Lo /C Hi ; green, Fig 2A) and one cluster (n 5 20) characterized by high tau uptake in both the ERC and cortex (E Hi /C Hi ; blue, Fig 2A) . Figure  2B shows the data in terms of its two (uncorrelated) principal components with ellipses representing the clusters. The voxel-level patterns of tau-PET uptake in each cluster compared to controls are shown in Figure 3 . Table) . The majority of subjects in both the E Lo /C Lo (81%) and E Hi /C Hi (80%) clusters had a clinical diagnosis of typical AD, whereas the majority of the subjects in the E Lo /C Hi cluster had a diagnosis of atypical AD (Fig 2A) . Distribution of the specific atypical clinical diagnoses did not differ across the three clusters, with most of the dysexecutive (71%), logopenic (43%), and posterior cortical atrophy (Table) . Figure 4 shows that the majority of subjects in the E Lo /C Lo cluster were over the age of 65 at the time of PET, except for 1 atypical AD subject. In contrast, the majority of subjects in the E Hi / C Hi cluster were under age 65. The subjects in the E Lo / C Hi cluster consisted of subjects under and over age 65.
In addition, disease duration was longer in the E Lo / C Lo cluster compared to the E Lo /C Hi cluster, and the E Lo /C Hi and E Hi /C Hi clusters both showed a lower global PiB ratio than the E Lo /C Lo cluster (Table) . 
Discussion
This study demonstrates that the severity of ERC and neocortical [ 18 F]AV-1451 tau-PET uptake varies considerably across the AD spectrum, and that the degree of uptake in these two regions maps well onto clinical presentation and age in AD. The cluster analysis utilized in this study was blinded to diagnosis and showed that patients best clustered into three groups when ERC and cortical tau uptake was considered. Most notably, the E Lo /C Lo cluster consisted of 35% of the cohort with subjects showing very little cortical uptake, but also relatively low levels of ERC uptake. At the group level, tau uptake in the ERC was greater than observed in controls, although the degree of ERC uptake was relatively low compared to the rest of our cohort. Elevated uptake was also observed in these subjects in other temporal regions, including the hippocampus, and in the posterior cingulate, which is functionally and structurally connected to the hippocampus. 42 The patients in the other two clusters all showed cortical uptake, particularly involving temporoparietal cortices, but also frontal and occipital lobes demonstrating widespread cortical tau uptake in these subjects and suggesting that they may have high Braak stage. Regional heterogeneity in neurofibrillary tangle deposition in AD has been previously recognized at autopsy, with subdivision of cases based on relative involvement of hippocampus and cortex. 43 A limbicpredominant variant was described that shows high neurofibrillary tangle counts in the hippocampus, but a relative sparing of cortex, and a hippocampal sparing variant was described showing high neurofibrillary tangle counts in the cortex, but relative sparing of the hippocampus. 43 The E Lo /C Lo cluster would most closely fit with the limbic-predominant variant, although the degree of tau uptake in the ERC was still relatively low in these subjects. It was somewhat surprising that we did not identify a tau-PET variant with low cortical uptake and high ERC uptake. It appears, instead, as though high ERC uptake is usually observed in the context of high cortical uptake. The reason for this discordance is unclear, but our finding of high ERC uptake in young AD makes sense given the fact that these subjects still had dominant memory impairment despite the high degree of cortical involvement. Volumes of the ERC and cortex somewhat reflected the tau findings (ie, more atrophy relating to greater tau uptake), although the volumes did not differ across clusters, suggesting that atrophy may be less sensitive to detect these clusters. The E Lo /C Hi cluster was also associated with young age, again supporting an association between age and cortical tau. However, the E Lo /C Hi cluster was more likely to be associated with an atypical clinical presentation of AD compared to either of the other clusters. The E Lo /C Hi cluster also showed poorer performance on tests of cognitive speed, executive function, and visuospatial function compared to the other clusters. This cluster showed the lowest ERC-cortex ratio, reflecting relatively less involvement of the ERC compared to cortex. Hence, we could hypothesize that the presence of atypical syndromes in this cluster is because the symptomatology coming from the cortex dominates over memory impairment coming from the medial temporal lobe. The reason that patients in the E Lo /C Hi cluster also showed lower cortical uptake than patients in the E Hi /C Hi cluster is unclear, but suggests that atypical AD subjects are different from young-onset typical AD subjects in the degree of both cortical and ERC tau uptake. However, asymmetry is often a feature of atypical AD, 12,13,44 and hence it is also possible that asymmetry in the patterns of cortical tau may have reduced the total cortical SUVR in this cluster, which is averaged across both hemispheres. We found a lower frequency of APOE e4 carriers in the E Lo /C Hi cluster, with only 48% of e4 carriers. Several studies report that APOE e4 frequency is lower in atypical clinical presentations compared to typical AD. 23, [45] [46] [47] Our results fit with these findings, but extend them to show that a lower APOE e4 frequency is particularly associated with high tau deposition in the cortex, but a relative sparing of the ERC. Conversely, higher APOE e4 frequencies were observed in the two clusters strongly associated with typical AD regardless of the pattern of tau deposition or average age of the cluster. Given the similarity in ERC uptake in the E Lo /C Lo and E Lo /C Hi clusters, our data do not support the notion that APOE e4 predisposes to medial temporal pathology. 48 We also observed a difference in global PiB SUVR across our groups, with higher values showing greater beta-amyloid deposition, in the E Lo /C Lo cluster, possibly reflecting the older age of this cluster. 49 A strength of our study is the large number of subjects and that our cohort represented both typical and atypical variants of AD. It should be noted, however, that we had a large proportion of young subjects in our cohort, and hence the expected proportion of subjects in each cluster may not generalize to all settings. Some potential limitations of the study include possible contributions of measurement noise, which could particularly affect measurements in a small structure like the ERC. Quantification of other structures could also be influenced by signal in the white matter and edge effects from the ventricles, for example, the posterior cingulate, which showed tau uptake in all three clusters. A potential issue with SUVR quantification is contamination of the normalization area from off-target binding and adjacent cortical signal. The crus region was selected to provide cerebellar gray matter in relative isolation from CSF spaces and to avoid adjacency to potential bleed-in from occipital, parahippocampal, and fusiform tau-pathology. 28 It has been shown that the tracer is not at an entirely stable state during late-uptake scans, but SUVR appears to model tangles very well even though its sensitivity to blood flow is uncertain. 50 Future autopsy correlation will be needed for further confirmation of the robustness of SUVR calculations. In summary, this study demonstrates considerable variability in [ 18 F]AV-1451 tau-PET uptake in AD. The findings suggest that considering uptake in the ERC and cortex will help explain some of the clinical heterogeneity observed in AD. It will be crucially important for future tau-PET studies in AD to consider this variability and account for a subject's specific tau-PET profile. Tau-PET provides the ideal opportunity to generate disease biomarkers for use in therapeutic trials in AD, but optimum biomarkers will almost certainly differ for the three clusters of subjects identified in this study. Stratification of subjects into one of these three groups using the degree of ERC and cortical tau uptake could be an important strategy in this regard to help appropriately target biomarkers and interpret therapeutic efficacy.
